Spectrum Pharmaceuticals

Spectrum Pharmaceuticals EBIT per Share

Delisted

The EBIT per Share of Spectrum Pharmaceuticals (SPPI) as of Nov 15, 2026 is -0.40 USD. In the previous year, EBIT per Share was -0.95 USD — a change of -58.45% (higher).

EBIT per Share

-0.40USD

YoY

-58.45%

Last updated:

EBIT per Share of Spectrum Pharmaceuticals is 2022 -0.40 USD. EBIT per Share of Spectrum Pharmaceuticals was 2021 -0.95 USD. It decreases by -58.45% higher compared to the previous year.

The Spectrum Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023 (e)
-0.21 USD
Jan 1, 2024 (e)
0.04 USD
Jan 1, 2025 (e)
0.29 USD
Jan 1, 2026 (e)
0.23 USD
Jan 1, 2027 (e)
0.44 USD
Jan 1, 2028 (e)
0.99 USD
Jan 1, 2029 (e)
1.24 USD
Jan 1, 2030 (e)
1.31 USD
The Spectrum Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
est1.31USD+5.46%
est1.24USD+25.17%
est0.99USD+127.97%
est0.44USD+90.62%
est0.23USD-20.24%
est0.29USD+594.14%
est0.04USD-119.78%
est-0.21USD-47.34%
-0.40USD-58.45%
-0.95USD-20.43%
-1.20USD-7.22%
-1.29USD+4.16%
-1.24USD+26.37%
-0.98USD+25.49%
-0.78USD+25.67%
-0.62USD+28.40%
-0.49USD-21.36%
-0.62USD-149.49%
1.25USD+32.22%
0.94USD-191.45%
-1.03USD+76.04%
-0.59USD-0.88%
-0.59USD-50.32%
-1.19USD+16.18%
-1.02USD+21.42%
-0.84USD-0.31%
-0.85USD-24.82%
-1.13USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Spectrum Pharmaceuticals Stock analysis

What does Spectrum Pharmaceuticals do? Spectrum Pharmaceuticals Inc. is an American biotechnology company specializing in the development and commercialization of drugs for the treatment of cancer and other serious diseases. It was founded in 1987 and is headquartered in Irvine, California. The company's CEO is Rajesh C. Shrotriya, who has a clear vision of specializing in pharmaceutical development to meet the needs of patients with unmet medical needs. Spectrum Pharmaceuticals has a wide range of products, with a focus on oncology and hematology. It also has a promising drug candidate pipeline. The company works closely with healthcare professionals and regulatory authorities to ensure the highest quality standards are met. Spectrum Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spectrum Pharmaceuticals stock

EBIT per Share of Spectrum Pharmaceuticals is -0.40 USD in 2022.

EBIT per Share of Spectrum Pharmaceuticals changed from -0.95 USD to -0.40 USD, representing a -58.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Spectrum Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Spectrum Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Spectrum Pharmaceuticals